1 |
Ahmad OB, Boschi-Pinto C, Lopez AD, et al (2001). Age standardization of rates: a new WHO standard. World Health Organization Geneva.
|
2 |
Benhamiche A-M, Faivre C, Minello A, et al (1998). Time trends and age-period-cohort effects on the incidence of primary liver cancer in a well-defined French population: 1976-1995. J Hepatol, 29, 802-6.
DOI
|
3 |
Chae HB, Kim J-H, Kim JK, et al (2009). Current status of liver diseases in Korea: hepatitis B. Korean J Hepatol, 15, S13-S24.
DOI
|
4 |
Dal Maso L, Lise M, Zambon P, et al (2008). Incidence of primary liver cancer in Italy between 1988 and 2002: An age-period-cohort analysis. Eur J Cancer, 44, 285-92.
DOI
|
5 |
Fang JW, Lai C, Chung H, et al (1994). Female children respond to recombinant hepatitis B vaccine with a higher titre than male. J Trop Pediatr, 40, 104-7.
DOI
|
6 |
Ferlay J, Soerjomataram I, Ervik M, et al GLOBOCAN 2012 v1. 0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. [cited 2015 Sep 13].
|
7 |
Fritz A, Percy C, Jack A, et al (2000). International classification of diseases for oncology. World Health Organization.
|
8 |
Gwack J, Park SK, Lee EH, et al (2011). Hepatitis B vaccination and liver cancer mortality reduction in Korean children and adolescents. Asian Pac J Cancer Prev, 12, 2205-8.
|
9 |
Jiang X, Pan SY, de Groh M, et al (2011). Increasing incidence in liver cancer in Canada, 1972-2006: Age-period-cohort analysis. J Gastrointest Oncol, 2, 223.
|
10 |
Jo MW, Khang YH, Yun S, et al (2004). Proportion of death certificates issued by physicians and associated factors in Korea, 1990-2002. J Prev Med Public Health, 37, 345-52.
|
11 |
Jung K-W, Park S, Kong H-J, et al (2012). Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat, 44, 11-24.
DOI
|
12 |
Jung KW, Won YJ, Kong HJ, et al (2015). Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat, 47, 127.
DOI
|
13 |
Kim H, Shin AR, Chung HH, et al (2013). Recent trends in hepatitis B virus infection in the general Korean population. Korean J Intern Med, 28, 413-9.
DOI
|
14 |
Kim HJ, Fay MP, Feuer EJ, et al (2000). Permutation tests for joinpoint regression with applications to cancer rates. Stat Med, 19, 335-51.
DOI
|
15 |
Kim SB, Lee WK, Choi H, et al (2009). A study on viral hepatitis markers and abnormal liver function test in adults living in northwest area of Chungnam. Korean J Gastroenterol, 53, 355-60.
DOI
|
16 |
Lee BS, Cho YK, Jeong SH, et al (2013). Nationwide seroepidemiology of hepatitis B virus infection in South Korea in 2009 emphasizes the coexistence of HBsAg and anti-HBs. J Med Virol, 85, 1327-33.
DOI
|
17 |
Lee KI, Park KS, Seo HJ, et al (2011). Shifting in seroprevalence of HBsAg and anti-HCV during recent 10 years in adults resident in Daegu and Gyeongbuk Province. Korean J Gastroenterol, 58, 82-7.
DOI
|
18 |
Lin HH, Wang LY, Hu CT, et al (2003). Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan. J Med Virol, 69, 471-4.
DOI
|
19 |
Matsuda T, Saika K (2012). Trends in liver cancer mortality rates in Japan, USA, UK, France and Korea based on the WHO mortality database. Jpn J Clin Oncol, 42, 360-1.
DOI
|
20 |
Morales S-VM, LlopisGonzalez L, Tejerizo PM (1993). Mortality rates of liver cancer in Spain: effect of age, birth cohort, and period of death. J Environ Pathol Toxicol Oncol, 13, 43-7.
|
21 |
Park KS, Lee YS, Lee SG, et al (2003). A study on markers of viral hepatitis in adults living in Daegu and Gyungbuk area. Korean J Gastroenterol, 41, 473-9.
|
22 |
Reither EN, Hauser RM, Yang Y (2009). Do birth cohorts matter? Age-period-cohort analyses of the obesity epidemic in the United States. Soc Sci Med, 69, 1439-48.
DOI
|
23 |
Statistics Korea [Internet]. Daejeon: Statistics Korea; 2013. [cited 2015 Oct 1].
|
24 |
Tzeng IS, Lee WC (2015). Forecasting hepatocellular carcinoma mortality in Taiwan using an age-period-cohort model. Asia Pac J Public Health, 27, 65-73.
DOI
|
25 |
Wang P, Xu C, Yu C (2014). Age-period-cohort analysis on the cancer mortality in rural China: 1990-2010. Int J Equity Health, 13, 1-12.
DOI
|
26 |
WHO (2009). Hepatitis B vaccines. Wkly Epidemiol Rec, 84, 405-19.
|
27 |
Yang Y (2008). Trends in US adult chronic disease mortality, 1960-1999: age, period, and cohort variations. Demography, 45, 387-416.
DOI
|
28 |
Yang Y, Fu WJ, Land KC (2004). A Methodological Comparison of Age-Period-Cohort Models: The Intrinsic Estimator and Conventional Generalized Linear Models. Sociol Methodol, 34, 75-110.
DOI
|
29 |
Yeo Y, Gwack J, Kang S, et al (2013). Viral hepatitis and liver cancer in Korea: an epidemiological perspective. Asian Pac J Cancer Prev, 14, 6227-31.
DOI
|
30 |
Zeeshan M, Jabeen K, Ali AN, et al (2007). Evaluation of immune response to Hepatitis B vaccine in health care workers at a tertiary care hospital in Pakistan: an observational prospective study. BMC Infect Dis, 7, 120.
DOI
|